SymBio Pharmaceuticals Limited
SYMQY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,807 | -$1,195 | $2,106 | $1,001 |
| Dep. & Amort. | $0 | $96 | $98 | $94 |
| Deferred Tax | $0 | $0 | -$790 | -$27 |
| Stock-Based Comp. | $93 | $82 | $105 | $124 |
| Change in WC | $263 | $1,068 | -$60 | -$1,067 |
| Other Non-Cash | $34 | -$246 | $155 | $14 |
| Operating Cash Flow | -$3,417 | -$195 | $1,614 | $140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$20 | -$204 | -$48 | -$64 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $16 | -$173 | $0 | -$7 |
| Investing Cash Flow | -$4 | -$377 | -$47 | -$71 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $729 | $681 | $662 | $0 |
| Stock Repurch. | -$20 | $0 | -$48 | -$73 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $14 | $0 |
| Financing Cash Flow | $708 | $680 | $628 | -$72 |
| Forex Effect | $159 | $125 | $214 | $14 |
| Net Chg. in Cash | -$2,553 | $234 | $2,422 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,517 | $6,283 | $3,860 | $3,849 |
| End Cash | $3,964 | $6,517 | $6,283 | $3,860 |
| Free Cash Flow | -$3,463 | -$427 | $1,567 | $76 |